Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,049 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

NCT02576496

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Cutaneous T Cell Lymphoma, +23 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Cancer Center Jacksonville, Florida, United States
  • Columbia University Medical Center New York, United States
  • University Hospitals Cleveland Seidman Cancer Center Cleveland, Ohio, United States
View all 18 locations
View Trial Details
Completed

A Study of Real-World Use of Ixazomib Citrate in People With Multiple Myeloma (MM)

NCT04840680

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • SOONCHUNHYANG UNIVERSITY HOSPITAL Bucheon Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
View all 20 locations
View Trial Details
Completed

Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma

NCT02654990

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Novartis Investigative Site Fayetteville, Arkansas, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Fort Collins, Colorado, United States
  • Novartis Investigative Site Gainesville, Florida, United States
View all 80 locations
View Trial Details
Completed

A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

NCT04659798

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations
  • H. Puerta del Mar Cadiz, Andalusia, Spain
  • Hospital Regional Universitario de Malaga (Carlos de Haya) Málaga, Andalusia, Spain
  • H. Universitari Son Espases Palma de Mallorca, Balearic Islands, Spain
  • H. Universitario de Araba Vitoria-Gasteiz, Basque Country, Spain
View all 14 locations
View Trial Details
Completed

A Study Evaluating The Safety And Pharmacokinetics Of Escalating Doses Of RO7297089 In Patients With Relapsed Or Refractory Multiple Myeloma

NCT04434469

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • LIVERPOOL HOSPITAL; HAEMATOLOGY; Ingham Institute for Medical Research Liverpool, New South Wales, Australia
  • Royal Adelaide Hospital; Haematology Clinical Trials Adelaide, South Australia, Australia
  • St. Vincent's Hospital Melbourne Fitzroy, South Australia, Australia
View Trial Details
Completed

TJ202, Lenalidomide and Dexamethasone vs. Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

NCT03952091

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Capital Medical University (CMU) - Beijing Chao-Yang Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Bengbu Medical college Bengbu, China
View all 41 locations
View Trial Details
Completed

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

NCT03439293

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Pacific Cancer Medical Center Anaheim, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • SCRI - Florida Cancer Specialists - Panhandle Tallahassee, Florida, United States
  • Research Medical Center - Kansas City Kansas City, Missouri, United States
View all 28 locations
View Trial Details

Related conditions